AEK-5508040-0/11/1

Novartis — FEI 3010301249

Refusal Details

Date
July 25, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
62GCE90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
Charges
75